Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1994 | 03-1994 | 12-1993 | 09-1993 | 06-1993 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -25,089 | N/A | N/A |
| Depreciation Amortization | N/A | N/A | 3,445 | N/A | N/A |
| Other Working Capital | N/A | N/A | -224 | N/A | N/A |
| Other Operating Activity | 0 | 0 | 551 | 0 | 0 |
| Operating Cash Flow | $N/A | $N/A | $-21,317 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -442 | N/A | N/A |
| Net Acquisitions | N/A | N/A | -154 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 3,921 | 0 | 0 |
| Investing Cash Flow | $N/A | $N/A | $3,324 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 19,485 | 0 | 0 |
| Financing Cash Flow | $N/A | $N/A | $19,485 | $N/A | $N/A |
| Beginning Cash Position | N/A | N/A | 2,796 | N/A | N/A |
| End Cash Position | N/A | N/A | 4,288 | N/A | N/A |
| Net Cash Flow | $N/A | $N/A | $1,492 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | -21,317 | N/A | N/A |
| Free Cash Flow | 0 | 0 | -21,317 | 0 | 0 |